Edwards Lifesciences Corp Stock Net Income

EW Stock  USD 95.56  0.41  0.43%   
Edwards Lifesciences Corp fundamentals help investors to digest information that contributes to Edwards Lifesciences' financial success or failures. It also enables traders to predict the movement of Edwards Stock. The fundamental analysis module provides a way to measure Edwards Lifesciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Edwards Lifesciences stock.
At this time, Edwards Lifesciences' Net Income is fairly stable compared to the past year. Net Income Applicable To Common Shares is likely to climb to about 1.8 B in 2024, whereas Net Income From Continuing Ops is likely to drop slightly above 836.3 M in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Edwards Net Income Analysis

Edwards Lifesciences' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Edwards Lifesciences Net Income

1.47 Billion

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Edwards Lifesciences Net Income

    
  1.4 B  
Most of Edwards Lifesciences' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Edwards Lifesciences Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Edwards Net Income Historical Pattern

Today, most investors in Edwards Lifesciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Edwards Lifesciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's net income growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Edwards Lifesciences net income as a starting point in their analysis.
   Edwards Lifesciences Net Income   
       Timeline  
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Edwards Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

(230.66 Million)

Edwards Lifesciences reported Accumulated Other Comprehensive Income of (242.8 Million) in 2023
Based on the recorded statements, Edwards Lifesciences Corp reported net income of 1.4 B. This is 310.04% higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 145.09% lower than that of the firm.

Edwards Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Edwards Lifesciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Edwards Lifesciences could also be used in its relative valuation, which is a method of valuing Edwards Lifesciences by comparing valuation metrics of similar companies.
Edwards Lifesciences is currently under evaluation in net income category among related companies.

Edwards Lifesciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Edwards Lifesciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Edwards Lifesciences' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Edwards Lifesciences Institutional Holders

Institutional Holdings refers to the ownership stake in Edwards Lifesciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Edwards Lifesciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Edwards Lifesciences' value.
Shares
Fmr Inc2023-12-31
7.5 M
Fisher Asset Management, Llc2023-12-31
7.1 M
Goldman Sachs Group Inc2023-12-31
M
Amundi2023-12-31
6.2 M
Morgan Stanley - Brokerage Accounts2023-12-31
6.1 M
Sands Capital Management, Llc2023-12-31
6.1 M
Northern Trust Corp2023-12-31
M
Hhg Plc2023-12-31
5.6 M
Legal & General Group Plc2023-12-31
5.5 M
Vanguard Group Inc2023-12-31
52.4 M
Blackrock Inc2023-12-31
52.2 M

Edwards Fundamentals

About Edwards Lifesciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Edwards Lifesciences Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Edwards Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Edwards Lifesciences Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Net Income1.4 B1.5 B
Net Income Applicable To Common Shares1.8 B1.8 B
Net Income From Continuing Ops1.4 B836.3 M
Net Income Per E B T 0.88  0.65 

Pair Trading with Edwards Lifesciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Edwards Stock

  0.89BSX Boston Scientific Corp Financial Report 24th of April 2024 PairCorr
  0.68COO Cooper Companies Financial Report 6th of June 2024 PairCorr

Moving against Edwards Stock

  0.86MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.81PHG Koninklijke Philips Financial Report 22nd of April 2024 PairCorr
  0.73MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.71PIIIW P3 Health PartnersPairCorr
  0.69TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Global Correlations
Find global opportunities by holding instruments from different markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.31
Revenue Per Share
9.897
Quarterly Revenue Growth
0.138
Return On Assets
0.1225
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.